Gracell Biotechnologies Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 5,465 | 0.00565% |
| Hedge Funds | 5,001,580 | 5.17% |
| General Public | 12,476,648 | 12.9% |
| Individual Insiders | 15,049,795 | 15.6% |
| Institutions | 22,320,122 | 23.1% |
| VC/PE Firms | 41,858,743 | 43.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 42.9%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 15,049,795 | US$154.2m | 0% | no data | |||
| 9,588,863 | US$98.2m | -3.16% | 0.1% | |||
| 9,546,485 | US$97.8m | -12.3% | 6.33% | |||
| 9,308,726 | US$95.4m | 0% | 1.31% | |||
| 8,333,333 | US$85.4m | 0% | 1.19% | |||
| 5,081,336 | US$52.1m | -61.3% | 7.61% | |||
| 5,001,580 | US$51.2m | 140% | 16.1% | |||
| 4,514,786 | US$46.3m | 48.6% | 3.24% | |||
| 2,191,417 | US$22.5m | 1,280% | 2.03% | |||
| 2,080,000 | US$21.3m | 108% | 0.24% | |||
| 1,461,000 | US$15.0m | 0% | 0.3% | |||
| 1,375,000 | US$14.1m | 0% | 2.35% | |||
| 1,350,000 | US$13.8m | 58.8% | 0.03% | |||
| 1,279,595 | US$13.1m | 0% | 2.13% | |||
| 1,278,454 | US$13.1m | 0% | 0.75% | |||
| 596,611 | US$6.1m | 0% | 0.82% | |||
| 539,973 | US$5.5m | -3.48% | no data | |||
| 517,274 | US$5.3m | 19,600% | 0.01% | |||
| 511,953 | US$5.2m | 76,900% | no data | |||
| 510,001 | US$5.2m | 5.26% | 0.2% | |||
| 502,936 | US$5.2m | -67.2% | 0.79% | |||
| 451,172 | US$4.6m | 0% | 0.51% | |||
| 400,000 | US$4.1m | 0% | 4.98% | |||
| 285,573 | US$2.9m | 0% | 0.14% | |||
| 275,000 | US$2.8m | 0% | no data |